Fabbrini G, Braun A, Mouradian M M, Tamminga C A, Chase T N
Experimental Therapeutics Branch, National Institute of Neurological and Communicative Disorders and Stroke, Bethesda, Maryland.
J Neural Transm. 1988;71(3):159-63. doi: 10.1007/BF01245709.
SKF 38393, a selective D-1 dopamine receptor agonist, elevated plasma prolactin levels in eight patients with various neurological disorders. Growth hormone concentrations were unaffected by SKF 38393 administration. The results suggest that D-1 receptors may be involved in the regulation of prolactin secretion.